Quintiles closes agreement to acquire Advion BioServices

Quintiles' ability to provide customers with actionable early-stage data to make better development decisions faster has taken a significant step forward with the closing of the previously announced agreement to acquire Advion BioServices, a premier U.S.-based bioanalytical laboratory.

“Adding Advion's world-class bioanalytical testing capabilities and expertise to our existing CAP-accredited central labs network creates a global one-stop solution for lab testing across the development spectrum”

Now known as Advion Bioanalytical Labs, a Quintiles company, the group provides Good Laboratory Practice (GLP) pharmacokinetic/pharmacodynamic (PK/PD) testing and other services to biopharma companies worldwide.

"Adding Advion's world-class bioanalytical testing capabilities and expertise to our existing CAP-accredited central labs network creates a global one-stop solution for lab testing across the development spectrum," said Thomas Wollman, Senior Vice President, Quintiles Global Laboratories. "I believe we now have unsurpassed abilities to help companies gather early-stage data and gain insights aimed at reducing the risk of failure in expensive later-stage trials."

Tom Kurz, Advion BioServices President and co-founder, said: "Quintiles' strong commitment to science, and to grow and expand our bioanalytical services globally, were two key drivers behind this agreement. We look forward to helping even more biopharma customers improve the efficiency and productivity of drug development now that we're part of Quintiles."

Advion BioServices has more than 180 employees at facilities in Ithaca, N.Y.; Manassas, Va.; and Indianapolis.

Quintiles Global Laboratories supports global and regional trials in almost every country in the world with wholly owned facilities in the U.S., Europe, South Africa, India, China, Singapore and Japan, and a tightly coordinated network of affiliate laboratories in Argentina and Brazil.

Source:

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Advion. (2019, June 24). Quintiles closes agreement to acquire Advion BioServices. News-Medical. Retrieved on July 12, 2024 from https://www.news-medical.net/news/20111107/Quintiles-closes-agreement-to-acquire-Advion-BioServices.aspx.

  • MLA

    Advion. "Quintiles closes agreement to acquire Advion BioServices". News-Medical. 12 July 2024. <https://www.news-medical.net/news/20111107/Quintiles-closes-agreement-to-acquire-Advion-BioServices.aspx>.

  • Chicago

    Advion. "Quintiles closes agreement to acquire Advion BioServices". News-Medical. https://www.news-medical.net/news/20111107/Quintiles-closes-agreement-to-acquire-Advion-BioServices.aspx. (accessed July 12, 2024).

  • Harvard

    Advion. 2019. Quintiles closes agreement to acquire Advion BioServices. News-Medical, viewed 12 July 2024, https://www.news-medical.net/news/20111107/Quintiles-closes-agreement-to-acquire-Advion-BioServices.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Advion announces appointment of Dr. Kaveh Kahen as new CEO David B. Patteson remains as group Chairman